EyeGene Market Cap

EyeGene has a market cap or net worth of 60.09 billion as of March 10, 2026. Its market cap has decreased by -16.43% in one year.

Market Cap

60.09B

Enterprise Value

36.60B

Revenue

4.10B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,390.00

Market Cap Chart

Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 60.09B, a decrease of -54.13%. That is a compound annual growth rate of -7.28%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	60.09B	-20.07%
Dec 30, 2025	75.18B	8.64%
Dec 30, 2024	69.20B	-24.46%
Dec 28, 2023	91.61B	-15.21%
Dec 29, 2022	108.04B	-73.58%
Dec 30, 2021	408.92B	175.32%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Aptamer Sciences	57.45B
SunBio,Inc.	64.75B
HLB Pep	64.87B
PanGen Biotech	67.13B
NGeneBio	53.15B
Ark Solutions	68.91B
CHA Vaccine Research Institute	72.80B
J2KBIO	45.32B

Market Cap Rankings